United States · 
What does Astellas Venture Management invest in?
Astellas Venture Management invests most often at Series B and Series A (69% of the rounds on record), in sectors such as Therapeutics and Platform Technologies.
Astellas Venture Management highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B and Series A: 69% of its rounds
- 03
Sole investor in 1 rounds, median undisclosed
- 04
3 exits from the portfolio
What they do
AVM is the wholly-owned venture capital organization within Astellas, dedicated to supporting pre-clinical, cutting-edge science that can bring VALUE to patients.From their own website
- Type
- Corporate VC
- Cheque size
- Not stated
- Stages
- Pre-seedSeedSeries A
- Sectors
- TherapeuticsPlatform Technologies
- Based in
- London, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first29 appearances
- 2026
1 round
- Apr
- 2021
1 round
- Mar
- 2019
2 rounds
- Nov
- Aug
- 2014
5 rounds
- Dec
- Oct
- Oct
- Oct
- Apr
- 2013
4 rounds
- Dec
- May
- Feb
- Jan
- 2012
3 rounds
- Dec
- Sept
- Jun
- 2011
3 rounds
- Oct
- Jul
- May
- 2010
2 rounds
- Sept
- Jun
- 2009
3 rounds
- Oct
- Jul
- Jan
- 2008
2 rounds
- Aug
- Jun
- 2007
1 round
- Aug
- 2006
2 rounds
- Sept
- Feb
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed3 in all
VerastemListed$52MJul 2013
EpizymeListed$60MMay 2013
Intradigm CorporationBought by Silence TherapeuticsUndisclosedDec 2009
An exit counts when it came after the firm's first round in the company. From historical deal records.